crohn's glp 1 GLP-1s may reduce steroid dependence in disease, obesity GLP-1 Use in Crohn's Disease:

There have been reports of darker freckles or moles appearing with MT2 use

Suite 202, Newport Beach, CA 92660, serves patients throughout Orange County and Los Angeles, and regularly welcomes patients traveling from across California and the entire United States for consultations and procedures

Treatment should continue only if there is a clinically meaningful response (for example, HbA1c reduction 11 mmol/mol and weight loss 3% at around 6 months)

These reactions typically manifest as localized skin changes at or near the injection site and are generally mild to moderate in severity

I hope FDA takes this same stance against all illegal compounding and counterfeit products